Highlights of Changes in Preferred Drug List (PDL) effective January 2016
Pristiq is now a preferred agent.
ProAir Respiclick is a non-preferred agent and requires trial and failure of a preferred albuterol MDI (ProAir HFA or Proventil HFA).
Flovent MDI switched from preferred to non-preferred status. Aerospan and Asmanex switched from non-preferred to preferred status. QVAR remains a preferred agent.
Celecoxib (generic Celebrex) is non-preferred and requires trial and failure (or contra-indication to) at least one preferred NSAID. Diclofenac immediate release switched from preferred to non-preferred status but diclofenac sustained release has remained a preferred agent.